Calcium and Vitamin D supplemention effects on menstrual cycle in Poly Systic Ovary Syndrome wome
Not Applicable
- Conditions
- Poly Cystic Ovary Syndrome.sclerocystic ovary syndrome-stein leventhal syndrome
- Registration Number
- IRCT201308037513N3
- Lead Sponsor
- Isfahan University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
include criteria:women in the range of 15-40 years of the age with Poly Cystic Ovary Syndrome that their Calcum(8.7-10.2mg/dl) and Creatinin(0.5-0.9mg/dl) serum are in normal range and they have vitamin D3 serum lower than normal{30ngr/ml}.
exclude criteria:
Cushing Syndrome?Renal Failur(Creatinin equal or upper than 1.5mg/dl)
Ovary and Adrenal Tumor that secreted Androgen?Primary and Secondary hyper Parathyroidism?Osteomalasia?Cancers?Gasterectomy?Mental Retardation?Anti Convuisive Drugs?Congenital Adrenal Hyperplasia and
secondary exclude criteria are Diarrhea?Vomiting?severe abdominal Distention.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Regularity of menstural cycle. Timepoint: monthly. Method of measurement: with write of mentural days by patient{interval of regular menses is 24-35days}.;Regularity of menstural cycle. Timepoint: in first and the end of period of treatment. Method of measurement: do sonography for determine of dominant folicle that it is criteria for ovulation and regularity of mense.
- Secondary Outcome Measures
Name Time Method Weight changes. Timepoint: before start of study and the end of study. Method of measurement: do with determinant of body mass index{BMI}.